ADHD Children With StutteringNCT05383430
Prevalence of Stuttering in Children With ADHD at Sohag University Hospital
An observational study of ADHD Children With Stuttering, run by Sohag University at 1 site in Egypt.
Trial summary
The majority of the latest research suggests that stuttering is associated with significantly elevated levels of trait and social anxiety. The prevalence of children who stutter and have attention deficit/ hyperactivity disorder (ADHD) ranges from 4 to 26%. About 10-20% of children who stutter might show ADHD. Read more about this study
- Who is it for?
- Ages 6 to 18 years
- Conditions the study is for
- ADHD Children With Stuttering
- What is being tested?
- : Conners rating scale-Stanford-Binet Intelligence Scales- stuttering severity index third edition (SSI-3) .
- How many people
- 50 participants
- Where
- 1 siteEgypt
- Study dates
- Jun 2022to Jun 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 18 years
- All sexes
- Child, Adult
Study population: ADHD children with stuttering -: Cross sectional observational study. Period of the study: one year from the date of acceptance of the protocol. Place of the study: at Neuropsychiatriy and Phoniatric units at Sohag University Hospital.
Who may be able to join
- All children with ADHD
Who cannot join
- 1-Children ageed below 6 years old. 2- children with ADHD with other behavioral and neurological disorders.
Trial locations and contacts
1 site in 1 country.
Abdelrahim a Sadek, professor contact
About this study
The majority of the latest research suggests that stuttering is associated with significantly elevated levels of trait and social anxiety. The prevalence of children who stutter and have attention deficit/ hyperactivity disorder (ADHD) ranges from 4 to 26%. About 10-20% of children who stutter might show ADHD.
Gender ( male) is the dominant risk factor for stuttering, as also applies to other neurodevelopmental disorders. Examples include attention deficit hyperactive disorder (ADHD), conduct disorder, tics and the Gilles de la Tourette syndrome (GTS). These neurodevelopmental disorders are the second -most prominent set of comorbidities with stuttering.
Read more
Attention-deficit hyperactivity disorder (ADHD) and stuttering share many characteristics in addition to temperament . A complex interplay of neural differences, with genetic and environmental components, has been reported as a possible cause of both disorders. In addition, both may appear more frequently in boys than in girls . Furthermore, it is emphasized that childhood stuttering can be accompanied by aspects of ADHD . Likewise, children exhibiting signs of ADHD more frequently display speech disfluencies than their peers.
It is suggested that children with stuttering and those without stuttering will display different profiles in terms of temperament, certain aspects of ADHD, and some types of anxiety. In addition, it is to be expected that there will be some correlations between these variables in children who stutter. However, it is not possible to draw definite conclusions about this issue that could be generalized to all children who stutter. Furthermore, there are very few studies that deal with combinations of these variables .
- Conditions
- ADHD Children With Stuttering
- Being tested
- : Conners rating scale-Stanford-Binet Intelligence Scales- stuttering severity index third edition (SSI-3) .
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
: Conners rating scale-Stanford-Binet Intelligence Scales- stuttering severity index third edition (SSI-3) .Diagnostic test
Questionaire tests for ADHD -IQ-Stuttering severity assessment
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of stuttering in ADHD children
assessment of stuttering in ADHD children
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 May 2022
- Study startJun 2022 (estimated)
- Primary completionJun 2023 (estimated)
- Study completionJun 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for ADHD Children With StutteringStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Samar Medhat Kamal Eldin, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05383430
- Sponsor's protocol ID
- Soh-Med-22-05-13
- Status last verified
- May 2022
- First submitted
- 16 May 2022
- Last updated
- 20 May 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Publications
Riley GD. A stuttering severity instrument for children and adults. J Speech Hear Disord. 1972 Aug;37(3):314-22. doi: 10.1044/jshd.3703.314. No abstract available.
PubMed 5057250Healey EC, Reid R. ADHD and stuttering: a tutorial. J Fluency Disord. 2003 Summer;28(2):79-92; quiz 93. doi: 10.1016/s0094-730x(03)00021-4.
PubMed 12809746Lan J, Song M, Pan C, Zhuang G, Wang Y, Ma W, Chu Q, Lai Q, Xu F, Li Y, Liu L, Wang W. Association between dopaminergic genes (SLC6A3 and DRD2) and stuttering among Han Chinese. J Hum Genet. 2009 Aug;54(8):457-60. doi: 10.1038/jhg.2009.60. Epub 2009 Jul 10.
PubMed 19590515Verkuijl N, Perkins M, Fazel M. Childhood attention-deficit/hyperactivity disorder. BMJ. 2015 May 20;350:h2168. doi: 10.1136/bmj.h2168. No abstract available.
PubMed 25994532
Study at a glance
From the registry record, last updated by the sponsor on 20 May 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence of Stuttering in Children With ADHD at Sohag University Hospital
- ClinicalTrials.gov ID
- NCT05383430
- Acronym / sponsor ID
- Soh-Med-22-05-13
- Conditions
- ADHD Children With Stuttering
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- Jun 2022 (estimated)
- Primary completion
- Jun 2023 (estimated)
- Study completion
- Jun 2023 (estimated)
- First posted
- 20 May 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The majority of the latest research suggests that stuttering is associated with significantly elevated levels of trait and social anxiety. The prevalence of children who stutter and have attention deficit/ hyperactivity disorder (ADHD) ranges from 4 to 26%. About 10-20% of children who stutter might show ADHD.
Gender ( male) is the dominant risk factor for stuttering, as also applies to other neurodevelopmental disorders. Examples include attention deficit hyperactive disorder (ADHD), conduct disorder, tics and the Gilles de la Tourette syndrome (GTS). These neurodevelopmental disorders are the second -most prominent set of comorbidities with stuttering.
Attention-deficit hyperactivity disorder (ADHD) and stuttering share many characteristics in addition to temperament . A complex interplay of neural differences, with genetic and environmental components, has been reported as a possible cause of both disorders. In addition, both may appear more frequently in boys than in girls . Furthermore, it is emphasized that childhood stuttering can be accompanied by aspects of ADHD . Likewise, children exhibiting signs of ADHD more frequently display speech disfluencies than their peers.
It is suggested that children with stuttering and those without stuttering will display different profiles in terms of temperament, certain aspects of ADHD, and some types of anxiety. In addition, it is to be expected that there will be some correlations between these variables in children who stutter. However, it is not possible to draw definite conclusions about this issue that could be generalized to all children who stutter. Furthermore, there are very few studies that deal with combinations of these variables .
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 6 to 18 years
- Sex
- All
- Age groups
- Child, Adult
- Study population
- ADHD children with stuttering -: Cross sectional observational study. Period of the study: one year from the date of acceptance of the protocol. Place of the study: at Neuropsychiatriy and Phoniatric units at Sohag University Hospital.
Key inclusion criteria (1 listed)
- All children with ADHD
Key exclusion criteria (1 listed)
- 1-Children ageed below 6 years old. 2- children with ADHD with other behavioral and neurological disorders.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| : Conners rating scale-Stanford-Binet Intelligence Scales- stuttering severity index third edition (SSI-3) .Questionaire tests for ADHD -IQ-Stuttering severity assessment | Diagnostic test | – |
Primary outcome
Prevalence of stuttering in ADHD children
Time frame: 1 year
assessment of stuttering in ADHD children
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 May 2022.
- Background: PubMed 5057250Riley GD. A stuttering severity instrument for children and adults. J Speech Hear Disord. 1972 Aug;37(3):314-22. doi: 10.1044/jshd.3703.314. No abstract available.
- Background: PubMed 12809746Healey EC, Reid R. ADHD and stuttering: a tutorial. J Fluency Disord. 2003 Summer;28(2):79-92; quiz 93. doi: 10.1016/s0094-730x(03)00021-4.
- Background: PubMed 19590515Lan J, Song M, Pan C, Zhuang G, Wang Y, Ma W, Chu Q, Lai Q, Xu F, Li Y, Liu L, Wang W. Association between dopaminergic genes (SLC6A3 and DRD2) and stuttering among Han Chinese. J Hum Genet. 2009 Aug;54(8):457-60. doi: 10.1038/jhg.2009.60. Epub 2009 Jul 10.
- Background: PubMed 25994532Verkuijl N, Perkins M, Fazel M. Childhood attention-deficit/hyperactivity disorder. BMJ. 2015 May 20;350:h2168. doi: 10.1136/bmj.h2168. No abstract available.
- Individual participant dataSharing planned: Yes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Abdelrahim a Sadek, professor contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of ADHD Children With Stuttering, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 20 May 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Samar M kamal eldein, resident doctor (01228011393, samermedhat@med.sohag.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of stuttering in ADHD children (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05383430, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2022.